AAPS PharmSciTech, an official journal of the American Association of Pharmaceutical Scientists, publishes papers that focus on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems. Innovative in its content and practices, AAPS PharmSciTech, an online-only journal, uses technologically-driven tools and methods by which the scientific community can more efficiently disseminate their research.  

The premier journals of the American Association of Pharmaceutical Scientists have established a position of leadership among pharmaceutical scientists and successfully disseminate expert, high-quality content to the pharmaceutical sciences community.

AAPS PharmSciTech produces papers that focus on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems. Innovative in its content and practices, the journal uses technologically-driven tools and methods through which the scientific community can more efficiently disseminate their research.

There are several notable features for AAPS PharmSciTech:
 
  • Has an 89% overall satisfaction score from Springer Nature surveys
  • Administers fast peer review:
    • Less than 1 day from submission to editor review     
    • Average first decision time is 30 days for manuscripts selected for peer review
    • Average time from submission to final decision is 89 days (includes time for revisions)
    • Response to inquiries within one business day, and direct access to the Editor-in-Chief 
  • Distinguished teams of international Editors and Editorial Advisory Board
  • International readership with nearly 500,000 downloads per year
  • Accepted manuscripts are published online within an average of 30 days (includes time for proof approval by authors)
  • Uses the continuous publishing model, so articles can be cited immediately upon publication
  • Full-text articles available at more than 8,000 institutions worldwide
  • Does not levy submission or publication charges (unless author chooses Open Choice)
  • Free color publication and supplemental files, including video

Journal information

Main Editor
  • Robert O. Williams
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.026 (2021)
Impact factor
3.951 (2021)
Five year impact factor
687,249 (2021)
Downloads

Latest articles

Journal updates

  • The AAPS Journals Make Use of Portable Peer Review

    If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals (AAPS Open, The AAPS Journal, AAPSPharmSciTech, or Pharmaceutical Research), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, allows us to share, between the portfolio, previous peer review comments and reviewer names, subject to approval of all parties. This can help speed up the assessment process, should the editor choose to make a decision on the basis of the comments and revision. Interested?  Email us with the name of the journal to which you are going to submit. Note: Portable peer review is opt-in only, available at the authors’ preference, and the reviewer identities and comments will only be shared between offices, not to the author.

  • AAPS PharmSciTech High Impact Article Award

    AAPS PharmSciTech High Impact Article Award Recognizing an article published in the last two years in AAPS PharmSciTech that is judged exceptional by the editors for its impact on pharmaceutical technology.

    Awardee/Corresponding Author: Peter Mack, Ph.D., Astrazeneca Co-Authors: Amber Doty, Jon Schroeder, Kou Vang, Mark Sommerville, Ph.D., Mervin Taylor, Brad Flynn, and David Lechuga-Ballesteros, Ph.D.

    Watch the video here.


  • Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger

    AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.

View all updates

Societies, partners and affiliations

About this journal

Electronic ISSN
1530-9932
Co-Publisher information
American Association of Pharmaceutical Scientists
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. Baidu
  4. CLOCKSS
  5. CNKI
  6. CNPIEC
  7. Chemical Abstracts Service (CAS)
  8. Dimensions
  9. EBSCO Discovery Service
  10. EMBASE
  11. Google Scholar
  12. INIS Atomindex
  13. Japanese Science and Technology Agency (JST)
  14. Journal Citation Reports/Science Edition
  15. Medline
  16. Meta
  17. Naver
  18. Norwegian Register for Scientific Journals and Series
  19. OCLC WorldCat Discovery Service
  20. Portico
  21. ProQuest-ExLibris Primo
  22. ProQuest-ExLibris Summon
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SCIE)
  27. TD Net Discovery Service
  28. UGC-CARE List (India)
  29. Wanfang
Copyright information

Rights and permissions

Springer policies

© American Association of Pharmaceutical Scientists